Twist Bioscience Corporation (NASDAQ: TWST) reported Q2 EPS of ($0.66), $0.05 worse than the analyst estimate of ($0.61). Revenue for the quarter came in at $92.79 million versus the consensus estimate of $92.04 million.

For earnings history and earnings-related data on Twist Bioscience Corporation (TWST) click here.